Unum Therapeutics Inc. (UMRX) financial statements (2021 and earlier)

Company profile

Business Address 200 CAMBRIDGE PARK DRIVE
CAMBRIDGE, MA 02140
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3756
Cash and cash equivalents3756
Receivables22
Other undisclosed current assets124
Total current assets:4181
Noncurrent Assets
Operating lease, right-of-use asset5
Property, plant and equipment23
Restricted cash and investments11
Other noncurrent assets00
Total noncurrent assets:95
TOTAL ASSETS:4986
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:75
Accounts payable32
Accrued liabilities12
Employee-related liabilities32
Other undisclosed accounts payable and accrued liabilities10
Deferred revenue1
Debt2 
Contract with customer, liability18
Other undisclosed current liabilities32
Total current liabilities:1325
Noncurrent Liabilities
Long-term debt and lease obligation4 
Operating lease, liability4
Liabilities, other than long-term debt 1
Deferred rent credit 1
Total noncurrent liabilities:41
Total liabilities:1826
Stockholders' equity
Stockholders' equity attributable to parent3260
Common stock00
Additional paid in capital156152
Accumulated other comprehensive loss (0)
Accumulated deficit(124)(92)
Total stockholders' equity:3260
TOTAL LIABILITIES AND EQUITY:4986

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
Gross profit:2210
Operating expenses(55)(46)
Operating loss:(32)(36)
Nonoperating income01
Investment income, nonoperating01
Other nonoperating income00
Net loss attributable to parent:(32)(35)
Preferred stock dividends and other adjustments (0)
Net loss available to common stockholders, diluted:(32)(35)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
Net loss:(32)(35)
Other comprehensive income00
Comprehensive loss, net of tax, attributable to parent:(32)(35)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: